Evidence map›Paper›PMID 30973807›Full record

ArticleCirculation research2019

Response by El Refaey et al to Letter Regarding Article, "Protein Phosphatase 2A Regulates Cardiac Na

Mona El Refaey, Hassan Musa, Sakima A Smith, Philip F Binkley, Elisa Bradley, Thomas J Hund, Peter J Mohler

Abstract readLetterComment
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mona El RefaeyThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Physiology and Cell Biology, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Hassan MusaThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Physiology and Cell Biology, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Sakima A SmithThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Internal Medicine, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Philip F BinkleyThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Internal Medicine, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Elisa BradleyThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Internal Medicine, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Thomas J HundThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Biomedical Engineering, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.
Peter J MohlerThe Dorothy M. Davis Heart & Lung Research Institute, The Frick Center for Heart Failure and Arrhythmia, Department of Internal Medicine, Department of Physiology and Cell Biology, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH.

Funding

Defining novel mechanisms for human arrhythmiaR35HL135754 · NHLBI · OHIO STATE UNIVERSITY · PI MOHLER, PETER J. · 2017 to 2023
$6.0M
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitabilityR01HL083422 · NHLBI · VANDERBILT UNIVERSITY · PI MOHLER, PETER J. · 2006 to 2016
$3.8M
Defining novel mechanisms for regulation of atrial INa and arrhythmiasR01HL134824 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY, MOHLER, PETER J. · 2017 to 2020
$3.0M
Training in Congenital and Acquired Heart DiseaseT32HL098039 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GARG, VIDU, MOHLER, PETER J. · 2009 to 2019
$2.5M
EHD proteins in cardiac membrane protein targeting and remodelingR01HL114383 · NHLBI · OHIO STATE UNIVERSITY · PI BOYDEN, PENELOPE ALTMAN, MOHLER, PETER J. · 2013 to 2016
$2.1M
Defining the Impact of E-Cigarettes on Cardiac PathophysiologyR01HL139348 · NHLBI · OHIO STATE UNIVERSITY · PI WOLD, LOREN EUGENE · 2017 to 2020
$1.9M
Translational Candidate-Gene Studies of Simvastatin-Induced Myopathy in African AmericansR01MD011307 · NIMHD · OHIO STATE UNIVERSITY · PI SMITH, SAKIMA AHMAD · 2017 to 2021
$1.9M
Spectrin-based regulation of cardiac remodeling and heart failureR01HL135096 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY · 2017 to 2020
$1.6M
Defining New Pathways in Heart Failure and ArrhythmiaK08HL135437 · NHLBI · OHIO STATE UNIVERSITY · PI SMITH, SAKIMA AHMAD · 2017 to 2021
$749k
NHLBI NIH HHS K08 HL135437NHLBI NIH HHS R01 HL083422NHLBI NIH HHS R01 HL114383NHLBI NIH HHS R01 HL134824NHLBI NIH HHS R01 HL135096NHLBI NIH HHS R01 HL139348NHLBI NIH HHS R35 HL135754NHLBI NIH HHS T32 HL098039NIMHD NIH HHS R01 MD011307
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HeartProtein Phosphatase 2SodiumProtein Phosphatase 2Sodium

Identifiers

PMID30973807
PMCPMC6601626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.